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Combinatorial Sarcodictyin Libraries
The sarcodictyins A (1, R = Me) and B (1, R = Et), originally isolated from a soft coral, are
complex natural products with potent antitumour activity through a taxol-like mode of action
(tubulin polymerisation and microtubule stabilisation). In a recent paper, a solid-phase
synthetic route to the sarcodictyins has been described, and this chemistry has been extended
to allow the preparation of a combinatorial sarcodictyin library (K.C. Nicolaou et al., J. Am.
Chem. Soc., 120, (1998), 10814-10826).
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The compounds were prepared on solid-phase by attachment of the central tricyclic structure
through a Wittig coupling on a C-4 attached aldehyde. The structures of the sarcodictyins
offer three positions for molecular diversity; variation of the groups on C-3, C-4 and C-8, and
libraries were prepared on polystyrene resin using radio-frequency encoding. The solid-phase
attachment was finally cleaved by a transketalisation reaction.
The compounds prepared were evaluated for their ability to induce tubulin polymerisation,
followed by cytotoxicity studies with ovarian cancer cells (1A9) including a couple of taxol-
resistant cell lines. Although the tubulin polymerisation activities were not in line with the
cytotoxicity for some of these compounds, in general terms the SAR derived suggested that
the C-8 sidechain was essential, both imidazole nitrogens are required, C-4 ketal substituents
are well tolerated and C-3 esters are preferred over amides.
--------------------------------------------------------------------------------------------------------------
1,4-Benzodiazepine-2,5-dione Libraries
Multicomponent reactions are favourite methods for the synthesis of combinatorial libraries as
the combination of several reagents readily lead to complex organic products in one step. The
Ugi reaction is probably the most well-known of the multicomponent reactions, and has been
used in the past to prepare a range of drug-like compounds including the 1,4-benzodiazepine-
2,5-diones (BDPs), a system known for its activity against the fibrinogen IIb-IIIa receptor and
as anticonvulsants.
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However the previously reported Ugi route to the BDP system has been suboptimal due to
low yields and the formation of numerous by-products, possibly due to undesired participation
of the anthranilic acid nitrogen in the Ugi reaction. The route to BDPs has now been improved
(C. Hulme et al., J. Org. Chem., 68, (1998), 8021-8023). The modified route to the BDP (2)
involves the use of a N-Boc-protected anthranilic acid, and requires a second, acid-catalysed
deprotection and cyclisation step to complete the synthesis.
Overall, this N-Boc protection strategy has resulted in higher yield and purities of the drug-
like BDP structures.
--------------------------------------------------------------------------------------------------------------
Libraries of β-turn mimics
The β-turn motif features prominently in a number of protein-protein and protein-peptide
interactions. Because of their ubiquity, low molecular weight mimics have potential for
inhibiting these processes and therefore have possible medicinal uses. Amongst the various
peptidomimetics that replicate the conformation of the β-turn, a recent publication describes a
new ring structure prepared using a key aromatic nucleophilic substitution (Y. Feng et al., J.
Am. Chem. Soc., 120, (1998), 10768-10769).
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The macrocyclic structure (3, n = 0-3) was designed such that an aromatic ring linked to an
amino acid side chain would form a ring that would induce a β-turn in the peptidic fragment.
The compounds were prepared on solid-phase with attachment through the terminal
carboxamide and the intermediates were cyclised by nucleophilic substitution of the aromatic
fluoride by oxygen, nitrogen or sulphur. Studies are in progress to apply these structures to a
medicinally significant target.
